Detalles de la búsqueda
1.
Activity of Plazomicin Tested against Enterobacterales Isolates Collected from U.S. Hospitals in 2016-2017: Effect of Different Breakpoint Criteria on Susceptibility Rates among Aminoglycosides.
Antimicrob Agents Chemother
; 64(5)2020 04 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32094137
2.
Polymyxin Susceptibility Testing and Interpretive Breakpoints: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST).
Antimicrob Agents Chemother
; 64(2)2020 01 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31767718
3.
The Infectious Diseases Society of America's 10 × '20 Initiative (10 New Systemic Antibacterial Agents US Food and Drug Administration Approved by 2020): Is 20 × '20 a Possibility?
Clin Infect Dis
; 69(1): 1-11, 2019 06 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-30715222
4.
The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program.
Antimicrob Agents Chemother
; 63(7)2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31010862
5.
Dilution Factor of Quantitative Bacterial Cultures Obtained by Bronchoalveolar Lavage in Patients with Ventilator-Associated Bacterial Pneumonia.
Antimicrob Agents Chemother
; 62(1)2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29038277
6.
Assessment of 30/20-Microgram Disk Content versus MIC Results for Ceftazidime-Avibactam Tested against Enterobacteriaceae and Pseudomonas aeruginosa.
J Clin Microbiol
; 56(6)2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29563198
7.
WCK 5222 (Cefepime-Zidebactam) Antimicrobial Activity against Clinical Isolates of Gram-Negative Bacteria Collected Worldwide in 2015.
Antimicrob Agents Chemother
; 61(5)2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28242660
8.
Antimicrobial Activity of High-Proportion Cefepime-Tazobactam (WCK 4282) against a Large Number of Gram-Negative Isolates Collected Worldwide in 2014.
Antimicrob Agents Chemother
; 61(4)2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28137811
9.
Determination of Disk Diffusion and MIC Quality Control Guidelines for High-Dose Cefepime-Tazobactam (WCK 4282), a Novel Antibacterial Combination Consisting of a ß-Lactamase Inhibitor and a Fourth-Generation Cephalosporin.
J Clin Microbiol
; 55(10): 3130-3134, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28794180
10.
WCK 5222 (cefepime/zidebactam) antimicrobial activity tested against Gram-negative organisms producing clinically relevant ß-lactamases.
J Antimicrob Chemother
; 72(6): 1696-1703, 2017 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28333332
11.
High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-ß-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center.
Clin Infect Dis
; 63(7): 954-958, 2016 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27313265
12.
Dalbavancin Activity When Tested against Streptococcus pneumoniae Isolated in Medical Centers on Six Continents (2011 to 2014).
Antimicrob Agents Chemother
; 60(6): 3419-25, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27001811
13.
Activity of Fusidic Acid Tested against Staphylococci Isolated from Patients in U.S. Medical Centers in 2014.
Antimicrob Agents Chemother
; 60(6): 3827-31, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27021326
14.
Results from the Solithromycin International Surveillance Program (2014).
Antimicrob Agents Chemother
; 60(6): 3662-8, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27044551
15.
Effect of the ß-Lactamase Inhibitor Vaborbactam Combined with Meropenem against Serine Carbapenemase-Producing Enterobacteriaceae.
Antimicrob Agents Chemother
; 60(9): 5454-8, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27381386
16.
Changes in the Frequencies of ß-Lactamase Genes among Enterobacteriaceae Isolates in U.S. Hospitals, 2012 to 2014: Activity of Ceftazidime-Avibactam Tested against ß-Lactamase-Producing Isolates.
Antimicrob Agents Chemother
; 60(8): 4770-7, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27216075
17.
Antimicrobial Activities of Ceftazidime-Avibactam and Comparator Agents against Gram-Negative Organisms Isolated from Patients with Urinary Tract Infections in U.S. Medical Centers, 2012 to 2014.
Antimicrob Agents Chemother
; 60(7): 4355-60, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27114273
18.
Results from Oritavancin Resistance Surveillance Programs (2011 to 2014): Clarification for Using Vancomycin as a Surrogate To Infer Oritavancin Susceptibility.
Antimicrob Agents Chemother
; 60(5): 3174-7, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26926647
19.
Linezolid Surveillance Results for the United States (LEADER Surveillance Program 2014).
Antimicrob Agents Chemother
; 60(4): 2273-80, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26833165
20.
Antimicrobial Activities of Ceftaroline and Comparator Agents against Bacterial Organisms Causing Bacteremia in Patients with Skin and Skin Structure Infections in U.S. Medical Centers, 2008 to 2014.
Antimicrob Agents Chemother
; 60(4): 2558-63, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26856825